Skip to main content
main-content
Top

Tip

Swipe om te navigeren naar een ander artikel

Gepubliceerd in: Journal of Autism and Developmental Disorders 4/2012

01-04-2012 | Letter to the Editor

Further Commentary on Mitochondrial Dysfunction in Autism Spectrum Disorder: Assessment and Treatment Considerations

Auteurs: Stephen R. Dager, Neva M. Corrigan, Annette Estes, Dennis W. W. Shaw

Gepubliceerd in: Journal of Autism and Developmental Disorders | Uitgave 4/2012

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

The authors respond to a recent letter (Rossignol and Frye 2011) critical of their paper, “Proton magnetic resonance spectroscopy and MRI reveal no evidence for brain mitochondrial dysfunction in children with autism spectrum disorder” (Corrigan et al. 2011). Further considerations regarding the assessment of mitochondrial dysfunction in autism spectrum disorder, and related treatment considerations, are discussed.
Literatuur
go back to reference Amundsen, L. B., Artru, A. A., Dager, S. R., Shaw, D. W. W., Friedman, S., Sparks, B., et al. (2005). Propofol sedation for longitudinal pediatric neuroimaging research. Journal of Neurosurg Anesthesiology, 17(4), 180–192. CrossRef Amundsen, L. B., Artru, A. A., Dager, S. R., Shaw, D. W. W., Friedman, S., Sparks, B., et al. (2005). Propofol sedation for longitudinal pediatric neuroimaging research. Journal of Neurosurg Anesthesiology, 17(4), 180–192. CrossRef
go back to reference Bianchi, M. C., Sgandurra, G., Tosetti, M., Battini, R., & Cioni, G. (2007). Brain magnetic resonance in the diagnostic evaluation of mitochondrial encephalopathies. Biosciene Reports, 27(1–3), 69–85. CrossRef Bianchi, M. C., Sgandurra, G., Tosetti, M., Battini, R., & Cioni, G. (2007). Brain magnetic resonance in the diagnostic evaluation of mitochondrial encephalopathies. Biosciene Reports, 27(1–3), 69–85. CrossRef
go back to reference Coleman, M., & Blass, J. P. (1985). Autism and lactic acidosis. Journal of Autism and Developmental Disorders, 15(1), 1–8. PubMedCrossRef Coleman, M., & Blass, J. P. (1985). Autism and lactic acidosis. Journal of Autism and Developmental Disorders, 15(1), 1–8. PubMedCrossRef
go back to reference Correia, C., Coutinho, A. M., Diogo, L., Grazina, M., Marques, C., Miguel, T., et al. (2006). Brief report: High frequency of biochemical markers for mitochondrial dysfunction in autism: no association with the mitochondrial aspartate/glutamate carrier SLC25A12 gene. Journal of Autism and Developmental Disorders, 36(8), 1137–1140. PubMedCrossRef Correia, C., Coutinho, A. M., Diogo, L., Grazina, M., Marques, C., Miguel, T., et al. (2006). Brief report: High frequency of biochemical markers for mitochondrial dysfunction in autism: no association with the mitochondrial aspartate/glutamate carrier SLC25A12 gene. Journal of Autism and Developmental Disorders, 36(8), 1137–1140. PubMedCrossRef
go back to reference Corrigan, N. M., Richards, T. L., Friedman, S. D., Petropoulos, H., & Dager, S. R. (2010). Improving 1H MRSI measurement of cerebral lactate for clinical applications. Psychiatry Research Neuroimaging, 182(1), 40–47. CrossRef Corrigan, N. M., Richards, T. L., Friedman, S. D., Petropoulos, H., & Dager, S. R. (2010). Improving 1H MRSI measurement of cerebral lactate for clinical applications. Psychiatry Research Neuroimaging, 182(1), 40–47. CrossRef
go back to reference Corrigan, N. M., Shaw, D. W. W., Richards, T. L., Estes, A. M., Friedman, S. D., Petropoulos, H., et al. (2011). Proton magnetic resonance spectroscopy and MRI reveal no evidence for brain mitochondrial dysfunction in children with autism spectrum disorder. Journal of Autism and Developmental Disorders. doi: 10.​1007/​s10803-011-1216-y.​ Corrigan, N. M., Shaw, D. W. W., Richards, T. L., Estes, A. M., Friedman, S. D., Petropoulos, H., et al. (2011). Proton magnetic resonance spectroscopy and MRI reveal no evidence for brain mitochondrial dysfunction in children with autism spectrum disorder. Journal of Autism and Developmental Disorders. doi: 10.​1007/​s10803-011-1216-y.​
go back to reference Dager, S. R. (2010). The vexing role of baseline: Implications for neuroimaging studies of panic disorder. International Journal of Psychophysiology, 78(1), 20–26. PubMedCrossRef Dager, S. R. (2010). The vexing role of baseline: Implications for neuroimaging studies of panic disorder. International Journal of Psychophysiology, 78(1), 20–26. PubMedCrossRef
go back to reference Dager, S. R., & Steen, R. G. (1992). Applications of magnetic resonance spectroscopy to the investigation of neuropsychiatric disorders. Neuropsychopharmacology, 6(4), 249–266. PubMed Dager, S. R., & Steen, R. G. (1992). Applications of magnetic resonance spectroscopy to the investigation of neuropsychiatric disorders. Neuropsychopharmacology, 6(4), 249–266. PubMed
go back to reference Dager, S. R., Friedman, S. D., Heide, A., Layton, M. E., Richards, T., Artru, A., et al. (1999). Two-dimensional proton echo-planar spectroscopic imaging of brain metabolic changes during lactate-induced panic. Archieves of General Psychiatry, 56(1), 70–77. CrossRef Dager, S. R., Friedman, S. D., Heide, A., Layton, M. E., Richards, T., Artru, A., et al. (1999). Two-dimensional proton echo-planar spectroscopic imaging of brain metabolic changes during lactate-induced panic. Archieves of General Psychiatry, 56(1), 70–77. CrossRef
go back to reference Dager, S. R., Friedman, S. D., Parow, A., Demopulos, C., Stoll, A. L., Lyoo, I. K., et al. (2004). Brain metabolic alterations in medication-free patients with bipolar disorder. Archieves of General Psychiatry, 61(5), 450–458. CrossRef Dager, S. R., Friedman, S. D., Parow, A., Demopulos, C., Stoll, A. L., Lyoo, I. K., et al. (2004). Brain metabolic alterations in medication-free patients with bipolar disorder. Archieves of General Psychiatry, 61(5), 450–458. CrossRef
go back to reference Dager, S. R., Corrigan, N. M., Richards, T. L., & Posse, S. (2008). Research applications of magnetic resonance spectroscopy to investigate psychiatric disorders. Topics in Magnetic Resonance Imaging, 19(2), 81–96. PubMedCrossRef Dager, S. R., Corrigan, N. M., Richards, T. L., & Posse, S. (2008). Research applications of magnetic resonance spectroscopy to investigate psychiatric disorders. Topics in Magnetic Resonance Imaging, 19(2), 81–96. PubMedCrossRef
go back to reference Dager, S., Corrigan, N., Richards, T., & Shaw, D. (2011). Brain chemistry: Magnetic resonance spectroscopy. In D. Amaral, G. Dawson, & D. Geshwind (Eds.), Autism Spectrum Disorder. Oxford: Oxford University Press. Dager, S., Corrigan, N., Richards, T., & Shaw, D. (2011). Brain chemistry: Magnetic resonance spectroscopy. In D. Amaral, G. Dawson, & D. Geshwind (Eds.), Autism Spectrum Disorder. Oxford: Oxford University Press.
go back to reference Dawson, G., Rogers, S., Munson, J., Smith, M., Winter, J., Greenson, J., et al. (2010). Randomized, controlled trial of an intervention for toddlers with autism: The early start denver model. Pediatrics, 125(1), e17–e23. PubMedCrossRef Dawson, G., Rogers, S., Munson, J., Smith, M., Winter, J., Greenson, J., et al. (2010). Randomized, controlled trial of an intervention for toddlers with autism: The early start denver model. Pediatrics, 125(1), e17–e23. PubMedCrossRef
go back to reference Friedman, S. D., Dager, S. R., Richards, T. L., Petropoulos, H., & Posse, S. (2000). Modeling brain compartmental lactate response to metabolic challenge: A feasibility study. Psychiatry Research, 98(1), 55–66. PubMedCrossRef Friedman, S. D., Dager, S. R., Richards, T. L., Petropoulos, H., & Posse, S. (2000). Modeling brain compartmental lactate response to metabolic challenge: A feasibility study. Psychiatry Research, 98(1), 55–66. PubMedCrossRef
go back to reference Friedman, S. D., Shaw, D. W., Artru, A. A., Richards, T. L., Gardner, J., Dawson, G., et al. (2003). Regional brain chemical alterations in young children with autism spectrum disorder. Neurology, 60(1), 100–107. PubMed Friedman, S. D., Shaw, D. W., Artru, A. A., Richards, T. L., Gardner, J., Dawson, G., et al. (2003). Regional brain chemical alterations in young children with autism spectrum disorder. Neurology, 60(1), 100–107. PubMed
go back to reference Friedman, S. D., Shaw, D. W. W., Artru, A. A., Dawson, G., Petropoulos, H., & Dager, S. R. (2006). Gray and white matter brain chemistry in young children with autism. Archives of General Psychiatry, 63(7), 786–794. PubMedCrossRef Friedman, S. D., Shaw, D. W. W., Artru, A. A., Dawson, G., Petropoulos, H., & Dager, S. R. (2006). Gray and white matter brain chemistry in young children with autism. Archives of General Psychiatry, 63(7), 786–794. PubMedCrossRef
go back to reference Granpeesheh, D., Tarbox, J., Dixon, D., Wilke, A. E., Allen, S., & Bradstreet, J. J. (2010). Randomized trial of hyperbaric oxygen therapy for children with autism. Research in Autism Spectrum Disorders, 4, 265–268. Granpeesheh, D., Tarbox, J., Dixon, D., Wilke, A. E., Allen, S., & Bradstreet, J. J. (2010). Randomized trial of hyperbaric oxygen therapy for children with autism. Research in Autism Spectrum Disorders, 4, 265–268.
go back to reference Haas, R. H., Parikh, S., Falk, M. J., Saneto, R. P., Wolf, N. I., Darin, N., et al. (2008). The in-depth evaluation of suspected mitochondrial disease. Molecular Genetics and Metabolism, 94(1), 16–37. PubMedCrossRef Haas, R. H., Parikh, S., Falk, M. J., Saneto, R. P., Wolf, N. I., Darin, N., et al. (2008). The in-depth evaluation of suspected mitochondrial disease. Molecular Genetics and Metabolism, 94(1), 16–37. PubMedCrossRef
go back to reference Jepson, B., Granpeesheh, D., Tarbox, J., Olive, M. L., Stott, C., Braud, S., et al. (2011). Controlled evaluation of the effects of hyperbaric oxygen therapy on the behavior of 16 children with autism spectrum disorders. Journal of Autism and Developmental Disorders, 41(5), 575–588. PubMedCrossRef Jepson, B., Granpeesheh, D., Tarbox, J., Olive, M. L., Stott, C., Braud, S., et al. (2011). Controlled evaluation of the effects of hyperbaric oxygen therapy on the behavior of 16 children with autism spectrum disorders. Journal of Autism and Developmental Disorders, 41(5), 575–588. PubMedCrossRef
go back to reference Lyoo, I. K., Dager, S. R., Kim, J. E., Yoon, S. J., Friedman, S. D., Dunner, D. L., et al. (2010). Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: A longitudinal brain imaging study. Neuropsychopharmacology, 35(8), 1743–1750. PubMed Lyoo, I. K., Dager, S. R., Kim, J. E., Yoon, S. J., Friedman, S. D., Dunner, D. L., et al. (2010). Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: A longitudinal brain imaging study. Neuropsychopharmacology, 35(8), 1743–1750. PubMed
go back to reference Morgan, P. (2007). When propofol is problematic. Paper presented at the12th annual joint winter meeting of the society of pediatric anesthesia and American academy of pediatrics., Phoenix, Arizona. Morgan, P. (2007). When propofol is problematic. Paper presented at the12th annual joint winter meeting of the society of pediatric anesthesia and American academy of pediatrics., Phoenix, Arizona.
go back to reference Oliveira, G., Diogo, L., Grazina, M., Garcia, P., Ataíde, A., Marques, C., et al. (2005). Mitochondrial dysfunction in autism spectrum disorders: A population-based study. Developmental Medicine and Child Neurology, 47(3), 185–189. PubMedCrossRef Oliveira, G., Diogo, L., Grazina, M., Garcia, P., Ataíde, A., Marques, C., et al. (2005). Mitochondrial dysfunction in autism spectrum disorders: A population-based study. Developmental Medicine and Child Neurology, 47(3), 185–189. PubMedCrossRef
go back to reference Parikh, S., Saneto, R., Falk, M. J., Anselm, I., Cohen, B. H., Haas, R., et al. (2009). A modern approach to the treatment of mitochondrial disease. Current Treatment Options in Neurology, 11(6), 414–430. PubMedCrossRef Parikh, S., Saneto, R., Falk, M. J., Anselm, I., Cohen, B. H., Haas, R., et al. (2009). A modern approach to the treatment of mitochondrial disease. Current Treatment Options in Neurology, 11(6), 414–430. PubMedCrossRef
go back to reference Posse, S., Dager, S. R., Richards, T. L., Yuan, C., Ogg, R., Artru, A. A., et al. (1997). In vivo measurement of regional brain metabolic response to hyperventilation using magnetic resonance: Proton echo planar spectroscopic imaging (PEPSI). Magnetic Resonance in Medicine, 37(6), 858–865. PubMedCrossRef Posse, S., Dager, S. R., Richards, T. L., Yuan, C., Ogg, R., Artru, A. A., et al. (1997). In vivo measurement of regional brain metabolic response to hyperventilation using magnetic resonance: Proton echo planar spectroscopic imaging (PEPSI). Magnetic Resonance in Medicine, 37(6), 858–865. PubMedCrossRef
go back to reference Ramocki, M. B., & Zoghbi, H. Y. (2008). Failure of neuronal homeostasis results in common neuropsychiatric phenotypes. Nature, 455(7215), 912–918. PubMedCrossRef Ramocki, M. B., & Zoghbi, H. Y. (2008). Failure of neuronal homeostasis results in common neuropsychiatric phenotypes. Nature, 455(7215), 912–918. PubMedCrossRef
go back to reference Rossignol, D. A., & Bradstreet, J. J. (2008). Evidence of mitochondrial dysfunction in autism and implications for treatment. American Journal of Biochemistry and Biotechnology, 4(2), 208–217. CrossRef Rossignol, D. A., & Bradstreet, J. J. (2008). Evidence of mitochondrial dysfunction in autism and implications for treatment. American Journal of Biochemistry and Biotechnology, 4(2), 208–217. CrossRef
go back to reference Rossignol, D. A., & Frye, R. E. (2011). Substantial problems with measuring brain mitochondrial dysfunction in autism spectrum disorder using magnetic resonance spectroscopy. Journal of Autism and Developmental Disorders. doi: 10.​1007/​s10803-011-1276-z. Rossignol, D. A., & Frye, R. E. (2011). Substantial problems with measuring brain mitochondrial dysfunction in autism spectrum disorder using magnetic resonance spectroscopy. Journal of Autism and Developmental Disorders. doi: 10.​1007/​s10803-011-1276-z.
go back to reference Rossignol, D. A., Rossignol, L. W., Smith, S., Schneider, C., Logerquist, S., Usman, A., et al. (2009). Hyperbaric treatment for children with autism: A multicenter, randomized, double-blind, controlled trial. BMC Pediatrics, 9, 21. PubMedCrossRef Rossignol, D. A., Rossignol, L. W., Smith, S., Schneider, C., Logerquist, S., Usman, A., et al. (2009). Hyperbaric treatment for children with autism: A multicenter, randomized, double-blind, controlled trial. BMC Pediatrics, 9, 21. PubMedCrossRef
go back to reference Saneto, R. P., Friedman, S. D., & Shaw, D. W. W. (2008). Neuroimaging of mitochondrial disease. Mitochondrion, 8(5–6), 396–413. PubMedCrossRef Saneto, R. P., Friedman, S. D., & Shaw, D. W. W. (2008). Neuroimaging of mitochondrial disease. Mitochondrion, 8(5–6), 396–413. PubMedCrossRef
Metagegevens
Titel
Further Commentary on Mitochondrial Dysfunction in Autism Spectrum Disorder: Assessment and Treatment Considerations
Auteurs
Stephen R. Dager
Neva M. Corrigan
Annette Estes
Dennis W. W. Shaw
Publicatiedatum
01-04-2012
Uitgeverij
Springer US
Gepubliceerd in
Journal of Autism and Developmental Disorders / Uitgave 4/2012
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432
DOI
https://doi.org/10.1007/s10803-011-1352-4